دورية أكاديمية

Clinical utility and validity of minoxidil response testing in androgenetic alopecia.

التفاصيل البيبلوغرافية
العنوان: Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
المؤلفون: Goren, Andy, Shapiro, Jerry, Roberts, Janet, McCoy, John, Desai, Nisha, Zarrab, Zoulikha, Pietrzak, Aldona, Lotti, Torello
المصدر: Dermatologic Therapy; Jan2015, Vol. 28 Issue 1, p13-16, 4p
مصطلحات موضوعية: BALDNESS, BALDNESS treatment, MINOXIDIL, SULFOTRANSFERASES, META-analysis, DIAGNOSIS, THERAPEUTICS
مستخلص: Clinical response to 5% topical minoxidil for the treatment of androgenetic alopecia ( AGA) is typically observed after 3-6 months. Approximately 40% of patients will regrow hair. Given the prolonged treatment time required to elicit a response, a diagnostic test for ruling out nonresponders would have significant clinical utility. Two studies have previously reported that sulfotransferase enzyme activity in plucked hair follicles predicts a patient's response to topical minoxidil therapy. The aim of this study was to assess the clinical utility and validity of minoxidil response testing. In this communication, the present authors conducted an analysis of completed and ongoing studies of minoxidil response testing. The analysis confirmed the clinical utility of a sulfotransferase enzyme test in successfully ruling out 95.9% of nonresponders to topical minoxidil for the treatment of AGA. [ABSTRACT FROM AUTHOR]
Copyright of Dermatologic Therapy is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13960296
DOI:10.1111/dth.12164